Skip to main content
Fig. 4 | Renal Replacement Therapy

Fig. 4

From: Estimated influence of a novel biocompatible dialysis membrane on vascular events in dialysis patients with diabetic nephropathy: a prospective randomized controlled pilot study

Fig. 4

Change in serum pentosidine concentration before dialysis during this study. a Individual data in the TORAYLIGHT NV (NV) group. b Individual data in the polysulfone (PS) group. c Averaged data in the NV group. d Averaged data in the PS group. Serum pentosidine concentrations were measured once per year. Data are presented as the mean ± standard deviation in C and D. **: p<0.01, *: p<0.05, ns : Not significant

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us